Daniela joined Lygature as a Project Communications Manager in January. She is a self-motivated, driven communications professional with experience in project coordination and management, and a passion for writing and content development. Within Lygature Daniela is involved in the following projects: Pediatric Praziquantel Consortium, DTECT-Schisto, GNA NOW, MOMENTUM and European Lead Factory.
Bianca joined Lygature in February as a Project Communication Manager. She has a background in communication and political science, and she joined Lygature coming from Springer Nature, where she worked in the biomedical department. She is also an experienced writer with an extensive portfolio of stories and interviews.
Bianca’s primary focus will be Oncode Institute. She shares “I am looking forward to helping Oncode realizing its mission and goals by uncovering and promoting all the stories that matter - whether about people, programmes, events or new discoveries.”
Jacqueline Staring joined as a Program manager for Lygature in February. She did her PhD in the lab of Thijn Brummelkamp where she studied picornavirus infections by performing genetic screens in human haploid cells. Afterwards she did a postdoc in the lab of Eske Willerslev where she studied pathogens from the past by sequencing ancient samples.
At first her focus in Lygature will be multiple programmes within Oncode – among others, the Drug Repurposing programme where she will support Oncode researchers with screening opportunities on a repurposed/abended compound library of 6000 compounds. Furthermore, she will join Oncode’s Technology Access and Equipment and Infrastructure programmes to improve and expand the technological expertise within the Oncode community.
Robin joined Lygature in March as a Program Manager and will be working on the BBMRI.nl and RSNN projects. Robin obtained his Bachelor’s degree in Health Sciences and his Master’s degree in Biomedical Sciences, both at Maastricht University.
His interest in cardiovascular research has brought him to carry out his PhD at the department of Cardiology at Cardiovascular Research Institute Maastricht (2013-2017). During the first years of his PhD, he was seconded as a researcher to the biotech company Cenix BioSciences (Dresden, Germany). After completing his doctoral thesis, he was honoured various postdoctoral grants to establish collaborations across Europe. The resulting studies describing the regulatory role of noncoding RNAs in cardiac disease have been published in peer-reviewed journals.